Bullish Case: Known: ORA ~$136.7, mean-reverting; calls trade ~70% > puts. ORA IV surface is mostly flat across strikes/tenors (~purple) with limited skew, and the ORA return surface shows highest likelihood bands at modest +10% to +60% over ~1–2y holds. Calibrated vs Feb–May: rangebound/mean-revert (46%) still fits; downside hasn’t stepped down. Oracle: mild bullish short-vol put-spread bias with tail hedge if put IV left-wing re-prices.

Bearish Case: Known uncertainty: catalysts/tax-credit/PUC timing not resolved. ORA downside tail IV (deep low strikes) shows sharp lift (orange/red) suggesting re-pricing risk. SPY IV surface has strong downside skew (cyan→orange/red to ~45), so a macro shock can quickly lift ORA put prices and correlations, breaking mean reversion. Calibrated: my prior regulatory slip (-10–15%) and SPY vol-shock (-15%+) remain viable because no hard evidence has reduced milestone risk.

Potential Outcomes:

ORA next:

1. 35% Range/mean-revert (−3%..+5%)—flat ORA IV surface; holds near $130–$145.
2. 30% Grind-up (+6%..+15% by Q4)—ORA return surface positive band + call-heavy flow.
3. 8% Tail up (+15%..+25%)—specific contract/M&A; falsify via SEC/PR + sustained call IV.
4. 17% Regulatory/PUC/tax-credit slip (−10%..−18%)—milestone pushed past ~2028/30; falsify via filings.
5. 10% Macro/SPY vol shock (−20%..−28%)—SPY downside IV wing expansion; falsify via SPY puts IV jump.

Oracle: put-spread if IV stays flat; hedge when wings widen.

June 11, 2026